NCT04786210View on ClinicalTrials.gov

Treatment of Keloids With Fractional Erbium Laser-Assisted 5-Fluorouracil Versus Laser-Assisted Corticosteroid

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 30, 2021

Primary Completion Date

December 16, 2022

Study Completion Date

December 16, 2022

Conditions
Keloid Scar
Interventions
COMBINATION_PRODUCT

Fractional erbium:YAG-assisted drug delivery of 5-fluorouracil

Split-scar fractional ablative erbium laser-assisted delivery of 50mg/mL of 5-fluorouracil solution to one half of the scar (4 treatments)

COMBINATION_PRODUCT

Fractional erbium:YAG-assisted drug delivery of triamcinolone acetonide

Split-scar fractional ablative erbium laser-assisted delivery of 10 mg/mL of triamcinolone acetonide solution to the other half of the scar (4 treatments)

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT04786210 - Treatment of Keloids With Fractional Erbium Laser-Assisted 5-Fluorouracil Versus Laser-Assisted Corticosteroid | Biotech Hunter | Biotech Hunter